110 related articles for article (PubMed ID: 2462975)
1. [Virus inactivation in blood products].
Stephan W
Beitr Infusionsther; 1988; 21():192-201. PubMed ID: 2462975
[No Abstract] [Full Text] [Related]
2. [Virus safety of fresh frozen plasma].
Sugg U
Beitr Infusionsther; 1989; 24():56-9. PubMed ID: 2481549
[TBL] [Abstract][Full Text] [Related]
3. Reducing the risk of virus transmission by blood products.
Thomas DP
Br J Haematol; 1988 Dec; 70(4):393-5. PubMed ID: 3064802
[No Abstract] [Full Text] [Related]
4. [Virus inactivation of plasma products. Practical methods and their safety].
Rübsamen-Waigmann H
Dtsch Med Wochenschr; 1994 Mar; 119(10):345-8. PubMed ID: 8125038
[No Abstract] [Full Text] [Related]
5. Viral inactivation of blood components: recent advances.
Horowitz B; Ben-Hur E
Transfus Clin Biol; 1996; 3(1):75-7. PubMed ID: 8640317
[No Abstract] [Full Text] [Related]
6. Virus inactivation of fresh plasma.
Mohr H
Vox Sang; 1998; 74 Suppl 2():171-2. PubMed ID: 9704442
[No Abstract] [Full Text] [Related]
7. At what stage should virus inactivation be carried out?
Dorner F; Barrett PN; Eibl J
Dev Biol Stand; 1993; 81():137-43. PubMed ID: 8174796
[TBL] [Abstract][Full Text] [Related]
8. Value of virus filtration as a method for improving the safety of plasma products.
Burnouf T
Vox Sang; 1996; 70(4):235-6. PubMed ID: 9123931
[No Abstract] [Full Text] [Related]
9. [Disinfection of endoscopic equipment: the desirable and the possible].
Bigard MA
Gastroenterol Clin Biol; 1990; 14(2):131-3. PubMed ID: 2184075
[No Abstract] [Full Text] [Related]
10. The development of virus-free labile blood derivatives--a review.
Prince AM; Horowitz B; Horowitz MS; Zang E
Eur J Epidemiol; 1987 Jun; 3(2):103-18. PubMed ID: 3301391
[TBL] [Abstract][Full Text] [Related]
11. Prevention of infectious disease transmission by blood and blood products.
Aronson DL; Menaché D
Prog Hematol; 1987; 15():221-41. PubMed ID: 3140296
[No Abstract] [Full Text] [Related]
12. [Viral inactivation of cellular blood products].
Andreu G
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):215-6. PubMed ID: 8337130
[No Abstract] [Full Text] [Related]
13. Viral safety of solvent-detergent treated blood products.
Horowitz B; Prince AM; Horowitz MS; Watklevicz C
Dev Biol Stand; 1993; 81():147-61. PubMed ID: 8174797
[TBL] [Abstract][Full Text] [Related]
14. Virus inactivation procedures: an overview.
Tedder R
Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S13-4. PubMed ID: 7495960
[TBL] [Abstract][Full Text] [Related]
15. [Viral safety considerations in immunoglobulin preparations].
Gómez Manzano P; Escrivá CA; Salmerón García F; Alonso Verduras C
Sangre (Barc); 1997 Jun; 42(3):199-203. PubMed ID: 9381262
[No Abstract] [Full Text] [Related]
16. [Trends in the evaluation of chemical disinfectants as virucides].
Weinhold E
Tierarztl Prax; 1973; 1(2):129-32. PubMed ID: 4807583
[No Abstract] [Full Text] [Related]
17. [Possibilities of virus inactivation of pooled fresh plasma with tri-n-butylphosphate (TNBP) detergents (SD procedure)].
Gürtler L
Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():77-9. PubMed ID: 8000260
[TBL] [Abstract][Full Text] [Related]
18. [Therapy with blood and blood products].
Kreienbühl G
Urologe A; 1996 Jan; 35(1):69-85. PubMed ID: 8851853
[No Abstract] [Full Text] [Related]
19. [Prevention of hospital infection: prevention of infection by blood-borne viruses].
Yoshihara N
Kango Tenbo; 1987 Sep; 12(10):977-9. PubMed ID: 3682912
[No Abstract] [Full Text] [Related]
20. Risk of virus transmission by tissue, blood, and plasma products.
Lelie PN; Zaaijer HL; Cuypers HT
Transplant Proc; 1996 Oct; 28(5):2939. PubMed ID: 8908132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
